IQVIA Pharma Deals Review
ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.
Pharma Deals Review Latest Articles
-
Lilly Signs US$8.85 B Oncology and Immunology Partnership with Innovent Biologics
-
AstraZeneca Signs US$18.5 B Licensing Pact with CSPC Pharmaceutical Group for Obesity and Type 2 Diabetes Treatments
-
Lilly Signs US$1.9 B Global Collaboration with Repertoire for Autoimmune Diseases
-
Boehringer Ingelheim and Simcere Forge US$1.26 B Collaboration to Advance Inflammatory Bowel Disease Bispecific Antibody
-
Madrigal Inks US$50 M Deal with Pfizer for DGAT-2 inhibitor Ervogastat for the Treatment of MASH
You can click on any of the bars to open a new page with the corresponding deals.
RSS